Cystatin SN Affects Cell Proliferation by Regulating the ERα/PI3K/AKT/ERα Loopback Pathway in Breast Cancer
Yanfang Liu,* Hong Ma,* Ye Wang, Xinyang Du, Jing Yao Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, People’s Republic of China*These authors contributed equally to this workCorrespondence: Jing YaoCancer Center, Union Ho...
Main Authors: | Liu Y, Ma H, Wang Y, Du X, Yao J |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-12-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/cystatin-sn-affects-cell-proliferation-by-regulating-the-eralphapi3kak-peer-reviewed-article-OTT |
Similar Items
-
ERα, A Key Target for Cancer Therapy: A Review
by: Liu Y, et al.
Published: (2020-03-01) -
Research progress of cystatin SN in cancer
by: Liu Y, et al.
Published: (2019-05-01) -
Extracellular HSP90α Interacts With ER Stress to Promote Fibroblasts Activation Through PI3K/AKT Pathway in Pulmonary Fibrosis
by: Jinming Zhang, et al.
Published: (2021-08-01) -
Apigenin, a Partial Antagonist of the Estrogen Receptor (ER), Inhibits ER-Positive Breast Cancer Cell Proliferation through Akt/FOXM1 Signaling
by: Thu Ha Pham, et al.
Published: (2021-01-01) -
Estrogen Signaling in ERα-Negative Breast Cancer: ERβ and GPER
by: Rainer Girgert, et al.
Published: (2019-01-01)